LLY

ELI LILLY & CO

LLY·532457108·US·Common Stock·Healthcare - Drug Manufacturers - General-13D/G

LLY (ELI LILLY & CO) is held by 397 institutional investors as of Q2 2026. Largest holders: LILLY ENDOWMENT INC ($108.4B), BlackRock, Inc. ($81B), VANGUARD CAPITAL MANAGEMENT LLC ($64.2B). Net institutional sentiment: Mixed. In Q2 2026, 13 members of Congress and 234 funds bought LLY.

397
Holders
(39 Elite)
$856.6B
Total Value
59% (394)
Consensus
234 buying - 160 selling
13F: Insider & Congress: Updated regularly
LLY

Smart Money Verdict

View all
Loading verdict
Held by 397 funds
39 elite

Who's Trading

Source dates: Price Sep 1, 2026 · Insiders Aug 18, 2026 · Activists Jul 23, 2026 · Congress Aug 24, 2026

InsiderLRLUCIANO JUAN RVest 13.453 shAug 17, 2026
InsiderSGSulzberger GabrielleVest 4.191 shAug 17, 2026
InsiderFEFyrwald J ErikVest 8.382 shAug 17, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
90.4M(-1.6%)$108.4B100.0%+894.40%
0
Increased
67.5M(+1.8%)$81B1.2%+51.58%
51
Increased
53.5M(+0.3%)$64.2B1.4%+27.99%
50
Decreased
51.3M(-0.0%)$61.6B30.5%+142.42%
0
Increased
36.2M(+1.7%)$43.4B1.3%+95.48%
51
Increased
28.5M(+8.1%)$34.1B1.5%+44.11%
54
Decreased
20.9M(-15.3%)$25B3.5%+78.35%
0
Decreased
20.9M(-0.6%)$25B1.1%+28.11%
0
Increased
20.3M(+0.6%)$24.3B1.3%+268.33%
50
Increased
16.2M(+5.1%)$19.5B1.0%+29.76%
53
Increased
15.9M(+1.8%)$19.1B2.3%+333.26%
56
Decreased
12.6M(-8.0%)$15.5B0.9%+52.77%
0
Increased
11.3M(+1.3%)$13.5B0.9%+51.87%
45
Decreased
11M(-18.1%)$13.2B2.3%+150.40%
0
Unchanged
10.8M$12.9B8.8%+1021.09%
0
Decreased
9.2M(-0.6%)$11B6.5%+1019.86%
0
Decreased
8.8M(-0.3%)$10.6B1.2%+428.35%
0
Increased
7.7M(+20.7%)$9.2B0.8%+38.67%
54
Increased
7.2M(+1.9%)$8.6B1.6%+128.67%
51
Increased
6M(+1.8%)$7.2B1.0%+257.79%
46

Showing 1-20 of 414

1 / 21
LLYLLYELI LILLY & CO

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used